Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rio

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Annals of Hematology|February 1, 1997
Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatmentM Hunault, D Zhou, A Delmer, et al.
British Journal of Cancer|July 19, 2006
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemiaV Lévy, S Zohar, C Bardin, et al.
British Journal of Haematology|October 16, 1999
Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de MoelleN Dhedin, S Giraudier, P Gaulard, et al.
Annales De Medecine Interne|January 1, 1996
[Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center]B Rio, Z Marjanovic, R Belhocine, et al.
Lancet (London, England)|August 11, 2001
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective surveyN Salooja, R M Szydlo, G Socie, et al.
Virology|December 9, 2000
Molecular epidemiology of human herpesvirus 8 in africa: both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespreadV Lacoste, J G Judde, J Brière, et al.
Bone Marrow Transplantation|April 20, 2004
Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cellsB Sirohi, R Powles, S Kulkarni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)E Jantunen, C Canals, M Attal, et al.
Bone Marrow Transplantation|November 9, 2004
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)M Mohty, M Attal, G Marit, et al.
Leukemia|January 20, 2009
Fully functional NK cells after unrelated cord blood transplantationV Beziat, S Nguyen, S Lapusan, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Annals of Hematology|February 1, 1997
Multidrug resistance gene expression in acute myeloid leukemia: major prognosis significance for in vivo drug resistance to induction treatmentM Hunault, D Zhou, A Delmer, et al.
British Journal of Cancer|July 19, 2006
A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemiaV Lévy, S Zohar, C Bardin, et al.
British Journal of Haematology|October 16, 1999
Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de MoelleN Dhedin, S Giraudier, P Gaulard, et al.
Annales De Medecine Interne|January 1, 1996
[Difference in costs of autologous transplantation of peripheral and bone marrow hematopoietic stem cells. A retrospective analysis over 1 year of transplantation in lymphoma, Hodgkin's disease and myeloma in a Center]B Rio, Z Marjanovic, R Belhocine, et al.
Lancet (London, England)|August 11, 2001
Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective surveyN Salooja, R M Szydlo, G Socie, et al.
Virology|December 9, 2000
Molecular epidemiology of human herpesvirus 8 in africa: both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespreadV Lacoste, J G Judde, J Brière, et al.
Bone Marrow Transplantation|April 20, 2004
Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cellsB Sirohi, R Powles, S Kulkarni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2011
Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)E Jantunen, C Canals, M Attal, et al.
Bone Marrow Transplantation|November 9, 2004
Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myélome (IFM) and the Société Française de Greffe de Moelle et Thérapie Cellulaire (SFGM-TC)M Mohty, M Attal, G Marit, et al.
Leukemia|January 20, 2009
Fully functional NK cells after unrelated cord blood transplantationV Beziat, S Nguyen, S Lapusan, et al.
Pageof 11